Bernd Berwanger
Overview
Explore the profile of Bernd Berwanger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
647
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Otto T, Horn S, Brockmann M, Eilers U, Schuttrumpf L, Popov N, et al.
Cancer Cell
. 2008 Dec;
15(1):67-78.
PMID: 19111882
In human neuroblastoma, amplification of the MYCN gene predicts poor prognosis and resistance to therapy. In a shRNA screen of genes that are highly expressed in MYCN-amplified tumors, we have...
2.
Schulte J, Horn S, Schlierf S, Schramm A, Heukamp L, Christiansen H, et al.
Cancer Lett
. 2008 Jul;
274(1):10-5.
PMID: 18639376
MicroRNAs constitute a family of small RNA species that regulate translation and stability of mRNA. This additional layer of epigenetic regulation has escaped discovery until recently, and introduces another level...
3.
Schulte J, Horn S, Otto T, Samans B, Heukamp L, Eilers U, et al.
Int J Cancer
. 2007 Oct;
122(3):699-704.
PMID: 17943719
MYCN amplification is a common feature of aggressive tumour biology in neuroblastoma. The MYCN transcription factor has been demonstrated to induce or repress expression of numerous genes. MicroRNAs (miRNA) are...
4.
Fulda S, Poremba C, Berwanger B, Hacker S, Eilers M, Christiansen H, et al.
Cancer Res
. 2006 Oct;
66(20):10016-23.
PMID: 17047064
Inactivation of caspase-8 because of aberrant gene methylation has been associated with amplification of the MYCN oncogene and aggressive disease in neuroblastoma, suggesting that caspase-8 may function as tumor suppressor....
5.
Nowak K, Kerl K, Fehr D, Kramps C, Gessner C, Killmer K, et al.
Nucleic Acids Res
. 2006 Apr;
34(6):1745-54.
PMID: 16582100
The oncogene BMI1 encodes a polycomb group transcription factor that is required for embryonic development and self-renewal of stem cells. Despite these important functions little is known about the regulation...
6.
Schramm A, Schulte J, Klein-Hitpass L, Havers W, Sieverts H, Berwanger B, et al.
Oncogene
. 2005 Aug;
24(53):7902-12.
PMID: 16103881
Neuroblastoma is a common childhood tumor comprising cases with rapid disease progression as well as spontaneous regression. Although numerous prognostic factors have been identified, risk evaluation in individual patients remains...
7.
Ceballos E, Munoz-Alonso M, Berwanger B, Acosta J, Hernandez R, Krause M, et al.
Oncogene
. 2005 Apr;
24(28):4559-71.
PMID: 15856024
We have previously demonstrated that c-Myc impairs p53-mediated apoptosis in K562 human leukemia cells, which lack ARF. To investigate the mechanisms by which c-Myc protects from p53-mediated apoptosis, we used...
8.
Berwanger B, Hartmann O, Bergmann E, Bernard S, Nielsen D, Krause M, et al.
Cancer Cell
. 2002 Nov;
2(5):377-86.
PMID: 12450793
Tumor stage, age of patient, and amplification of MYCN predict disease outcome in neuroblastoma. To gain insight into the underlying molecular pathways, we have obtained expression profiles from 94 primary...